Related Experiment Video
Updated: Aug 15, 2025

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
Blood pressure in heart failure management and prevention
Daichi Maeda1, Taishi Dotare1, Yuya Matsue2
1Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Insights
Hypertension significantly impacts heart failure development and prognosis. Effective blood pressure management, considering heart failure treatments, is crucial for cardiovascular health and patient outcomes.
Area of Science:
- Cardiology
- Hypertension Research
- Heart Failure Pathophysiology
Background:
- Hypertension is a primary driver of cardiovascular diseases, including heart failure.
- The mechanisms linking hypertension to heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) differ.
- Blood pressure management is critical for preventing heart failure and influencing prognosis in affected patients.
Purpose of the Study:
- To explore how hypertension contributes to HFrEF and HFpEF.
- To examine the effect of hypertension on the incidence of heart failure.
- To review optimal blood pressure management strategies in heart failure patients.
Main Methods:
- Literature review of studies on hypertension, heart failure, and blood pressure management.
- Analysis of the relationship between blood pressure and cardiovascular events in patients with and without heart failure.
- Discussion of the impact of guideline-directed medical therapy (GDMT) for heart failure on blood pressure.
Main Results:
- The association between systolic blood pressure (SBP) and cardiovascular events is linear in non-heart failure patients but J-shaped or inverse linear in heart failure patients.
- Heart failure medications influence blood pressure and their efficacy depends on baseline blood pressure.
- Blood pressure management and pharmacotherapy differ significantly between patients with and without heart failure.
Conclusions:
- Understanding the distinct roles of hypertension in HFrEF and HFpEF is essential.
- Rigorous blood pressure control can reduce heart failure incidence.
- Tailored blood pressure management, considering GDMT, is vital for optimizing outcomes in heart failure patients.
Abstract:
Hypertension is a leading cause of heart failure and other cardiovascular diseases. Its role in the pathogenesis of heart failure with reduced ejection fraction (HFrEF) differs from that in heart failure with preserved ejection fraction (HFpEF). Moreover, rigorous blood pressure control may reduce the incidence of heart failure. However, once heart failure develops, prognosis is affected by blood pressure, which may differ between patients with and without heart failure. Therefore, the association between guideline-directed medical therapy (GDMT) for heart failure and its uptitration must be considered for blood pressure management and should not be overlooked. Heart failure medications affect the blood pressure and efficacy per baseline blood pressure value. This review discusses the potential mechanisms by which hypertension leads to HFrEF or HFpEF, the impact of hypertension on incident heart failure, and the recommended approaches for blood pressure management in patients with heart failure. Comparison between patients with and without heart failure regarding blood pressure The association between CV events and SBP is linear in patients without heart failure; however, it becomes J-shaped or inverse linear in those with heart failure. The management of BP, including optimal BP or pharmacotherapy, differs between the two populations. ACEi angiotensin-converting enzyme inhibitors, ARB angiotensin II receptor blockers; ARNi angiotensin receptor-neprilysin inhibitors, BB beta-blockers, BP blood pressure, CV cardiovascular, DASH Dietary Approaches to Stop Hypertension, GDMT guideline-directed medical therapy, HF heart failure, HFrEF heart failure with reduced ejection fraction, MRA mineralocorticoid receptor antagonists, SBP systolic blood pressure, SGLT2i sodium-glucose cotransporter 2 inhibitors.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
08:12Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS
Published on: November 26, 2018
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
Heart Failure VI: Adjunct Therapies
Heart Failure II: Pathophysiology
Hypertension V: Nursing Management
Heart Failure Drugs: Diuretics